Literature DB >> 11266629

Coupling of antibodies via protein Z on modified polyoma virus-like particles.

S Gleiter1, H Lilie.   

Abstract

Therapeutic application of virus-based delivery systems often implies a change of the tropism of these vectors. This can be achieved by insertion of polypeptides (e.g., antibody fragments) in viral coat proteins. Such fusion proteins have only been used in viral vectors so far and, as part of a virus, they have not been available for a detailed biophysical characterization. We analyzed a fusion protein called VP1-Z, which is based on the polyoma virus coat protein VP1 and protein Z. Protein Z is an engineered antibody-binding domain derived from protein A from Staphylococcus aureus. The fusion VP1-Z was constructed by insertion of protein Z in the HI-loop of VP1. As wild-type VP1, VP1-Z formed pentameric capsomers and assembled to VLPs in vitro. The stability of these particles was very similar compared to that of VLPs of wild-type VP1. Protein Z was fully structured in the fusion protein and was still capable of binding antibodies on the surface of VLPs of VP1-Z. Using this fusion protein, we could change the tropism of polyoma VLPs toward cells presenting on their surface the antigen of the coupled antibody.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266629      PMCID: PMC2373932          DOI: 10.1110/ps.31101

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.

Authors:  F Martin; J Kupsch; Y Takeuchi; S Russell; F L Cosset; M Collins
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

2.  Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids.

Authors:  E Soeda; N Krauzewicz; C Cox; J Stokrová; J Forstová; B E Griffin
Journal:  Gene Ther       Date:  1998-10       Impact factor: 5.250

3.  NMR study of the interaction between the B domain of staphylococcal protein A and the Fc portion of immunoglobulin G.

Authors:  H Gouda; M Shiraishi; H Takahashi; K Kato; H Torigoe; Y Arata; I Shimada
Journal:  Biochemistry       Date:  1998-01-06       Impact factor: 3.162

4.  Amplification of ColE1 related plasmids in recombinant cultures of Escherichia coli after IPTG induction.

Authors:  A Teich; H Y Lin; L Andersson; S Meyer; P Neubauer
Journal:  J Biotechnol       Date:  1998-10-08       Impact factor: 3.307

5.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.

Authors:  R Freund; R L Garcea; R Sahli; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.

Authors:  T Stehle; Y Yan; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

7.  Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.

Authors:  H Braun; K Boller; J Löwer; W M Bertling; A Zimmer
Journal:  Biotechnol Appl Biochem       Date:  1999-02       Impact factor: 2.431

8.  Quantitative analysis of protein far UV circular dichroism spectra by neural networks.

Authors:  G Böhm; R Muhr; R Jaenicke
Journal:  Protein Eng       Date:  1992-04

9.  Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner.

Authors:  E Samuelsson; T Moks; B Nilsson; M Uhlen
Journal:  Biochemistry       Date:  1994-04-12       Impact factor: 3.162

10.  Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies.

Authors:  A Jiang; T H Chu; F Nocken; K Cichutek; R Dornburg
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  10 in total

1.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

3.  A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.

Authors:  Simone Grasso; Chiara Lico; Francesca Imperatori; Luca Santi
Journal:  Transgenic Res       Date:  2012-10-30       Impact factor: 2.788

4.  Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes.

Authors:  Helge Ewers; Alicia E Smith; Ivo F Sbalzarini; Hauke Lilie; Petros Koumoutsakos; Ari Helenius
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-11       Impact factor: 11.205

5.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

Review 6.  Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.

Authors:  B Schwarz; M Uchida; T Douglas
Journal:  Adv Virus Res       Date:  2016-11-08       Impact factor: 9.937

Review 7.  Relevant uses of surface proteins--display on self-organized biological structures.

Authors:  Anika C Jahns; Bernd H A Rehm
Journal:  Microb Biotechnol       Date:  2011-09-09       Impact factor: 5.813

8.  Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles.

Authors:  Ambily Abraham; Usha Natraj; Anjali A Karande; Ashutosh Gulati; Mathur R N Murthy; Sathyabalan Murugesan; Pavithra Mukunda; Handanahal S Savithri
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

Review 9.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 10.  Intracellular targeting with engineered proteins.

Authors:  Shane Miersch; Sachdev S Sidhu
Journal:  F1000Res       Date:  2016-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.